Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Photography, body maps and lesion monitoring

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Escalate urgently when assessment for Photography, body maps and lesion monitoring reveals systemic toxicity, airway or eye involvement, extensive skin failure, a non-blanching eruption in an unwell patient, or a rapidly changing lesion suspicious for aggressive malignancy.

Synopsis

Create consented, standardised and securely governed skin images and body maps that support comparison, referral and surveillance without delaying biopsy of suspicious change.

  • Obtain and document consent for image capture, storage and each proposed secondary use; clinical-care consent does not automatically authorise teaching or publication.
  • Use an overview image to locate the site, a regional view for distribution and a close-up with scale, focus and neutral colour reference when appropriate.
  • Body maps must specify side, landmark, lesion number and date so a later clinician can find the same lesion.
  • Store images only in the approved clinical record or secure system; personal phones, consumer cloud backups and informal messaging create confidentiality risk.
  • For Photography, body maps and lesion monitoring, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
  • A technically adequate result in Photography, body maps and lesion monitoring can still be misleading when the wrong lesion, site, preparation or clinical question was selected.

Key red flags

Do not substitute serial photography for urgent referral or tissue diagnosis when a lesion is rapidly changing, nodular, ulcerated, bleeding or otherwise clinically suspicious.

Safeguarding and dignity

Images involving children, intimate skin or coercive circumstances need particularly careful consent, chaperoning and access control.

Cancer warning change

New nodularity, rapid enlargement, spontaneous bleeding or ulceration requires clinical reassessment rather than another routine photograph.

Investigation priorities

01
Overview, regional and close-up image setFirst step

Record distribution, location and morphology at complementary scales.

Management branches

Planned assessmentUse serial clinical imaging systematically

The patient is stable and the result will alter diagnosis, referral or follow-up.

  1. Define the question for Photography, body maps and lesion monitoring, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
  3. Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the photography, body maps and lesion monitoring assessment and its recorded clinical context.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • GMC making and using visual and audio recordingsConsent, confidentiality, storage and secondary use of clinical images.
  • NICE NG14 melanoma assessment and managementDermoscopy, baseline photography and specialist assessment recommendations.
  • NICE NG12 suspected cancer recognition and referralUrgent referral features for suspected skin malignancy.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom